L-(−)-Norepinephrine (+)-bitartrate salt monohydrate
SIGMA/A9512 - ≥99%, solid
Synonym: L-(−)-Noradrenaline (+)-bitartrate salt monohydrate
CAS Number: 108341-18-0
Empirical Formula (Hill Notation): C8H11NO3 · C4H6O6 · H2O
Molecular Weight: 337.28
MDL Number: MFCD00150449
Linear Formula: C8H11NO3 · C4H6O6 · H2O
Product Type: Chemical
assay | ≥99% |
color | white |
form | solid |
InChI | 1S/C8H11NO3.C4H6O6.H2O/c9 |
InChI key | LNBCGLZYLJMGKP-LUDZCAPTSA |
Quality Level | 200 |
SMILES string | O.O[C@H]([C@@H](O)C(O)=O) |
solubility | H2O: 46 mg/mL |
Application: | • to infuse dogs to form a intracellular lipid accumulation model • to analyse the signaling involved in the up-regulation of monocarboxylate transporter 2 (MCT2) expression in cultured cortical neuron • in neurochemical preparation to study the response of gram-negative and gram-positive bacteria to norepinephrine • to study the roles of peripheral hormones on thyroid activity of turtles |
Biochem/physiol Actions: | Norepinephrine bitartrate plays an important role in in vivo and in vitro development of pathogenic and indigenous bacteria. It acts as a vasoconstrictor and adrenergic neurotransmitter. |
Caution: | Light sensitive |
Packaging: | 1, 5 g in glass bottle |
Packaging: | 250 mg in glass bottle |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H300 + H310 |
Precautionary statements | P262 - P264 - P270 - P280 - P301 + P310 - P302 + P352 + P310 |
Hazard Codes | T+ |
Risk Statements | 26/27/28 |
Safety Statements | 22-26-36/37/39-45 |
RIDADR | UN 2811 6.1 / PGII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥99% |
UNSPSC | 12352200 |